Several authors have extensively demonstrated the expression of GBM markers, such as EGFR, MGMT, IDH1 R132H, and ATRX, in tumor cells using IHC, which is much more applicable for neuropathology routine [39,40,41,42,43,44,45,46]. This evidence concerns the gene MGMT and glioblastoma.